Discover 198 paid clinical trials in Jackson, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 198
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
1 location in Jackson
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
for
Non Small Cell Lung Cancer,
2 locations in Jackson
Sponsor: PrECOG, LLC.
Sex: All
Age: 18+
Code: NCT06538038
Recruiting
Active & Responsive
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
for
Family Dynamics, Trust in Healthcare System, Family Structure,
1 location in Jackson
Sponsor: Jackson State University
Sex: Female
Age: 18 - 45
Code: NCT06481631
Recruiting
Active & Responsive
Neuromodulation to Reduce Muscle Stiffness Following Spinal Cord Injury
for
Spinal Cord Injuries, Spinal Cord Injury,
2 locations in Jackson
Sponsor: University of Mississippi Medical Center
Sex: All
Age: 18+
Code: NCT06274021
Early_phase1, Recruiting
Active & Responsive
Transcutaneous Spinal Stimulation for Lower Limb Spasticity in Spinal Cord Injury
for
Spinal Cord Injuries, Spasticity, Muscle
2 locations in Jackson
Sponsor: University of Mississippi Medical Center
Sex: All
Age: 18+
Code: NCT05457205
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South
for
HIV Prevention
1 location in Jackson
Sponsor: Rhode Island Hospital
Sex: Male
Age: 18 - 34
Code: NCT05087680
Recruiting
Active & Responsive
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
1 location in Jackson
Sponsor: PedAL BCU, LLC
Sex: All
Age: 0 - 21
Code: NCT05183035
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
for
Primary IgA Nephropathy
1 location in Jackson
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05797610
Phase3, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
1 location in Jackson
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase3, Recruiting
Active & Responsive
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry